Aurovela 24 Fe Kit
Product Images NDC 65862-934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aurovela 24 Fe (NDC 65862-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Norethindroneethinyl Fig1)

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

FDA Label Image

Figure (Norethindroneethinyl Fig3)

FDA Label Image

Figure A (Norethindroneethinyl Fig4)

Figure A (Norethindroneethinyl Fig4)
This text provides information on various birth control methods and the associated rates of pregnancy. It highlights the effectiveness of different methods, with fewer pregnancies occurring with methods such as implants, injections, intrauterine devices, and sterilization, while more pregnancies occur with methods such as birth control pills, skin patches, and vaginal rings with hormones. Condoms and diaphragms have moderate effectiveness. The text also mentions the use of natural family planning methods such as tracking the most fertile days of the monthly cycle and using spermicide or withdrawal. Finally, the text notes the option of not using birth control at all.*
FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton Label)

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton Label)
Aurovela™ 24 Fe is a 28 day regimen oral contraceptive which contains 24 light yellow to yellow tablets and 4 brown tablets, intended to prevent pregnancy. This product is not a protection against sexually transmitted diseases such as AIDS. Each light yellow to yellow tablet contains norethindrone acetate USP, 1 mg; ethinyl estradiol USP, 20mcg; and each brown tablet contains ferrous fumarate USP, 75 mg. The usual dosing required is one tablet per day; however, it is advisable to follow the full prescribing information provided in the package insert. The package should be stored at a controlled room temperature between 20° to 25°C (68° to 77°F).*
FDA Label Image

Norethindroneethinyl Fig7

Norethindroneethinyl Fig7
Aurovela 24 Fe is an oral contraceptive that is intended to prevent pregnancy, but it does not protect against sexually transmitted infections. It contains Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Tablets. Each pack contains 24 active pills and 4 inactive iron pills. The standard dose is one pill per day for 28 days or as instructed by a doctor. The package contains instructions and warning labels and should be kept out of the reach of children. Distributed by Aurobindo Pharma USA, Inc. in NJ, it is made in India.*
FDA Label Image

Structure-1 (Norethindroneethinyl Str1)

FDA Label Image

Structure-2 (Norethindroneethinyl Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.